MedTrace Logo

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

NCT06975969 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-03-05

No results posted yet for this study

Summary

Assess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.

Conditions

Interventions

DEVICE

Versus™ Endovascular Pulmonary Artery Drug Delivery Catheter

The Versus Pulmonary Artery Catheter is a dual-tip, infusion catheter. Two lumens access and deliver physician-specified fluids, including thrombolytics, into the pulmonary arteries of each lung via a single access site. The Secondary Catheter tip telescopes independently to facilitate infusion into the contralateral lung. The device may allow for assessment of a patient's hemodynamic condition through direct intracardiac and pulmonary artery pressure monitoring. Pressure is measured through an interface between the catheter's fluid lumen and an externally located, FDA-cleared, pressure transducer. The device may include an additional lumen that is in communication with a distal flow-directed balloon.

Sponsors & Collaborators

  • Liquet Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Luke Wilkins, MD · University of Virgina (UVA)

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-05
Primary Completion
2026-02-20
Completion
2026-02-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06975969 on ClinicalTrials.gov